Asia Scientific Global is a company focusing on the research and development of new inhaled drugs. It was co-founded in 2022 by outstanding talents who combine professional patent layouts and rich capital market experience, led by the world's top respiratory preparation research and development team. In addition to its current laboratory in Taiwan, ASG will establish a second laboratory in Singapore in 2024. Currently, it has set up offices and local teams in China and North America to simultaneously carry out relevant planning for subsequent product research and development, clinical trials and market development. , using Asia as its new R&D base, deploying the global market, and accelerating the clinical trial process of new drugs.